Source: International Congress 2019 – Rare lung diseases
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Kreuter (Heidelberg, Germany), K. Geissler (Bietigheim-Bissingen, Germany). The future of treatment for interstitial lung diseases: the patient’s and physician’s perspective. International Congress 2019 – Rare lung diseases

Member's Comments

No comment yet.

Related content which might interest you: Supportive care of patients with fibrosing interstitial lung disease: answering a great clinical need Source: Breathe, 16 (3) 200066; 10.1183/20734735.0066-2020 Year: 2020 The value of a specialist nurse-lead interstitial lung disease clinic, patients’ views Source: International Congress 2015 – Kaleidoscope of nursing research Year: 2015 Smoking-related lung diseases: a clinical perspective Source: Eur Respir J 2010; 35: 231-233 Year: 2010 Challenges to travelling with a lung condition: a patient perspective Source: International Congress 2017 – Air travel for respiratory patients Year: 2017 EPIDIA: an App to to assist physicians in the care of patients with interstitial lung diseases Source: Virtual Congress 2021 – Biomarkers and e-health in idiopathic interstitial pneumonia Year: 2021 Diagnosis of interstitial lung diseases and impact of guidelines: an issue only for pulmonologists? Source: Annual Congress 2007 - Controversies in the management of interstitial lung diseases Year: 2007 Impact of a specialist respiratory pharmacist in the management of interstitial lung disease Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: from the bench to the bedside Year: 2018 Contemporary challenges for specialist nursing in interstitial lung disease Source: Breathe, 14 (1) 36; 10.1183/20734735.014917 Year: 2018 The lung cancer patient, the pneumologist and palliative care: a developing alliance Source: Eur Respir J 2015; 45: 211-226 Year: 2015 The significance of addind rheumatological assessment to the multidisciplinary team in the diagnosis of interstitial lung disease. Source: International Congress 2017 – Best clinical practice for the management of chronic lung diseases Year: 2017 A focus group to explore the views of patients with non-malignant lung disease about end of life planning and care Source: Annual Congress 2009 - Organisation of care for individuals with chronic respiratory disease Year: 2009 Interims analysis of the EXCITING-ILD registry (registry for exploring clinical and epidemiological characteristics of interstitial lung diseases) Source: International Congress 2016 – ILD: from the bench to the bedside Year: 2016 Early diagnosis of fibrotic interstitial lung disease: challenges and opportunities Source: Virtual Congress 2021 – Interstitial lung diseases: from disease mechanisms to novel treatment options Year: 2021 An international survey on genetics in clinical practice for interstitial lung disease. Source: Virtual Congress 2021 – Exercise tolerance, supportive care and more in non-pulmonary fibrosis interstitial lung diseases Year: 2021 Unclassifiable interstitial lung disease: a pathologist's perspective Source: Eur Respir Rev, 27 (147) 170132; 10.1183/16000617.0132-2017 Year: 2018 Balancing treatment and side-effects in severe asthma: a patient and professional perspective Source: Breathe, 17 (2) 210045; 10.1183/20734735.0045-2021 Year: 2021 Treatment of interstitial lung diseases: current approaches and future directions Source: Virtual Congress 2021 – Interstitial lung diseases: from disease mechanisms to novel treatment options Year: 2021 The chest physician as the lung cancer patient’s guide: defining the role of the modern day chest physician throughout the lung cancer continuum Source: International Congress 2017 – PG1 Re-defining the role of chest physicians in lung cancer: new opportunities in diagnostics and therapy Year: 2017 My experience of pulmonary rehabilitation: a patient perspective Source: International Congress 2019 – Effects of pulmonary rehabilitation other than improving exercise capacity Year: 2019